As Advair sales erode, Benlysta gets EMA nod - FiercePharma
Links shared publicly online about this topic.
- 147total visits
As Advair sales erode, Benlysta gets EMA nod - FiercePharma
Has GlaxoSmithKline's ($GSK) Benlysta hit the market just in time? As the company celebrated the FDA nod for its new lupus drug, to be marketed in partnership with Human Genome Sciences, and then Read more...
View full resource at fiercepharma.com
Tags: Asthma Medication, COPD Medication, Lupus, Drug, FDA, Advair, GlaxoSmithKline
Most Recently Shared on July 14, 2011 at 3:54 pm By:
As Advair sales erode, Benlysta gets EMA nod. http://bit.ly/pEyn6V
Advertisement
